Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Effects of Rosiglitazone and Glimepiride, Both Given in Combination With Metformin, on 24-Hour Glycemia in Type 2 Diabetes Patients Not Controlled With Metformin Alone. A 3-Month Multicentre, Randomized, Parallel-Group, Open-Label Study.

NCT00318656 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00318656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00318656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Effects of Rosiglitazone and Glimepiride, Both Given in Combination With Metformin, on 24-Hour Glycemia in Type 2 Diabetes Patients Not Controlled With Metformin Alone. A 3-Month Multicentre, Randomized, Parallel-Group, Open-Label Study.
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2005
Completion date
October 31, 2007
Enrollment
23 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

non-insulin-dependent diabetes mellitus